Virtu Financial’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Virtu Financial’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-43,251	Closed	-$9K	–	2268
2024 Q3	$9K	Buy	43,251 +30,756	+246%	+$9.83K	﹤0.01%	1215
2024 Q2	$3K	Sell	12,495 -1,798	-13%	-$1.07K	﹤0.01%	1200
2024 Q1	$12K	Sell	14,293 -374	-3%	-$256	﹤0.01%	1235
2023 Q4	$6K	Buy	+14,667	New	+$11.7K	﹤0.01%	1464

Other funds holding RNLX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

IIC

Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Virtu Financial's RNLX Position: Q4 2024 in Review

Virtu Financial sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 43,251 shares — an estimated $9K sold.

Virtu Financial first reported a position in RNLX in Q4 2023 and held it in 4 quarters. The position peaked at $12K in Q1 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

Virtu Financial reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Virtu Financial sold 43,251 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $9K.
Virtu Financial first reported a position in Renalytix plc American Depositary Shares in Q4 2023 and held it in 4 quarters.
Virtu Financial's Renalytix plc American Depositary Shares position peaked at $12K in Q1 2024.
3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.